Skip to main content
Article thumbnail
Location of Repository

Bipolar disorders: treatment options and patient satisfaction

By Charles Bowden and Vivek Singh


Functional recovery, the goal of treatment, has long been overlooked in the assessment of effectiveness of pharmacological treatments. However, with the recent shift in paradigm, from syndromal–symptomatic recovery to functional recovery, there appears to be a new interest in the definition and evaluation of functional recovery. Since functional recovery lags symptomatic recovery, sometimes by months or years, the attainment of functional recovery will be determined by both efficacy and long-term compliance. Quetiapine, due to its efficacy in both mania and depression, and effect on cognition may lead to improved functioning in patients with bipolar disorder

Topics: Reviews
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. 2000.Functional impairment and cognition in bipolar disorder. Psychiatr Q,
  2. (2005). A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium monotherapy for mania in bipolar disorder.
  3. (2005). A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
  4. (2000). A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry,
  5. (2001). A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatr Scand,
  6. (2005). Burden of manic versus depressive symptoms in subjects with bipolar disorder. [journal title and biblio details].Neuropsychiatric Disease and Treatment 2006:2(2) 153 Bipolar disorders
  7. (2000). Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
  8. (1998). Cognitive deficits, psychopathology, and psychosocial functioning in bipolar mood disorder.
  9. (1998). Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A prelimianry study.
  10. (2003). Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.
  11. (1994). Efficacy of divalproex vs lithium and placebo in the treatment of mania.
  12. et al; on behalf of the Aripiprazole Study Group 2005. Effectivenss of aripiprazole v. haloperiodol in acute bipolar mania: double-blind, randomised, coparative 12-week trial.
  13. (2001). Impact of family burden and patient symptom status on clinical outcome in bipolar affective disorder.
  14. Krishnan AA 2004.Quality of life in patients with bipolar I depression: data from 920 patients. Bipolar Disord,
  15. (1996). Lithium use and discontinuation in a health maintenance organization.
  16. (2001). Lower suicide risk with longterm lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand,
  17. (1998). Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better.
  18. (2002). Olanzapine versus divalproex in the treatment of acute mania.
  19. (1990). Outcome in mania: a four year prospective follow-up of 75 patients utilizing survival analysis.
  20. (1990). Outcome in manic disorders: A naturalistic follow-up study.
  21. (2001). Principles of effectivenss trials and their implementation in VA Cooperative Study #430: Reducing the efficacy-effectiveness gap in bipolar disorder.
  22. (2005). Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium or placebo.
  23. (2001). Strategies to reduce misdiagnosis of bipolar depression.
  24. (1989). Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry,
  25. (2003). The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings.
  26. (2002). The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry,
  27. (2002). The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
  28. (2005). Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry,
  29. (2000). Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.